Non-small Cell Lung Cancer (NSCLC), Stage IV

Also known as: Non-small-cell Lung Cancer (NSCLC) Stage IV / Stage 4 Non-small cell lung cancer / Lung Cancer Non-small Cell Stage IV / Non-small Cell Lung Cancer (NSCLC) Stage IV / Non-small cell lung cancer stage IV / Non-small cell lung cancer metastatic

Drug	Drug Name	Drug Description
DB00441	Gemcitabine	A nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer.

Drug	Drug Name	Target	Type
DB00441	Gemcitabine	Ribonucleoside-diphosphate reductase large subunit	target
DB00441	Gemcitabine	UMP-CMP kinase	target
DB00441	Gemcitabine	Thymidylate synthase	target
DB00441	Gemcitabine	Cytidine deaminase	enzyme
DB00441	Gemcitabine	Deoxycytidine kinase	enzyme
DB00441	Gemcitabine	P-glycoprotein 1	transporter
DB00441	Gemcitabine	Multidrug resistance-associated protein 7	transporter
DB00441	Gemcitabine	Equilibrative nucleoside transporter 1	transporter
DB00441	Gemcitabine	DNA	target
DB00441	Gemcitabine	Sodium/nucleoside cotransporter 1	transporter
DB00441	Gemcitabine	Equilibrative nucleoside transporter 2	transporter
DB00441	Gemcitabine	Solute carrier family 28 member 3	transporter

Drug	Drug Name	Phase	Status	Count
DB05928	Dovitinib	1	Terminated	1
DB00530	Erlotinib	1	Terminated	1
DB00135	Tyrosine	1	Terminated	1
DB09330	Osimertinib	2	Recruiting	1
DB00958	Carboplatin	3	Recruiting	2
DB06643	Denosumab	3	Active Not Recruiting	1
DB12349	Dulanermin	3	Active Not Recruiting	1
DB01229	Paclitaxel	3	Recruiting	1
DB00642	Pemetrexed	3	Recruiting	1
DB00945	Acetylsalicylic acid	Not Available	Not Yet Recruiting	1
DB09330	Osimertinib	Not Available	Not Yet Recruiting	1